JP2007169203A - Whitening cosmetics and skin external preparations containing Kusunohakebomo extract - Google Patents
Whitening cosmetics and skin external preparations containing Kusunohakebomo extract Download PDFInfo
- Publication number
- JP2007169203A JP2007169203A JP2005367559A JP2005367559A JP2007169203A JP 2007169203 A JP2007169203 A JP 2007169203A JP 2005367559 A JP2005367559 A JP 2005367559A JP 2005367559 A JP2005367559 A JP 2005367559A JP 2007169203 A JP2007169203 A JP 2007169203A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- whitening
- genus
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 33
- 230000002087 whitening effect Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 12
- 241000863498 Urophyllum Species 0.000 claims abstract description 10
- 235000002818 Vaccinium dunalianum Nutrition 0.000 claims abstract description 10
- 241000733416 Vaccinium dunalianum Species 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 241000208422 Rhododendron Species 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 30
- 102000003425 Tyrosinase Human genes 0.000 abstract description 21
- 108060008724 Tyrosinase Proteins 0.000 abstract description 21
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 20
- 230000002401 inhibitory effect Effects 0.000 abstract description 14
- 235000006708 antioxidants Nutrition 0.000 abstract description 11
- 201000008937 atopic dermatitis Diseases 0.000 abstract description 10
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 8
- 230000019612 pigmentation Effects 0.000 abstract description 8
- 230000009759 skin aging Effects 0.000 abstract description 7
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 6
- 206010014970 Ephelides Diseases 0.000 abstract description 6
- 208000003351 Melanosis Diseases 0.000 abstract description 6
- 206010000496 acne Diseases 0.000 abstract description 6
- 208000001840 Dandruff Diseases 0.000 abstract description 5
- 206010012434 Dermatitis allergic Diseases 0.000 abstract description 5
- 206010012438 Dermatitis atopic Diseases 0.000 abstract description 5
- 206010042496 Sunburn Diseases 0.000 abstract description 5
- 208000010668 atopic eczema Diseases 0.000 abstract description 5
- 206010064127 Solar lentigo Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 239000003755 preservative agent Substances 0.000 description 9
- -1 L-ascorbic acid glucoside Chemical class 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000007764 o/w emulsion Substances 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229960000271 arbutin Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002211 L-ascorbic acid Substances 0.000 description 4
- 235000000069 L-ascorbic acid Nutrition 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006388 chemical passivation reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- DVWSXZIHSUZZKJ-UHFFFAOYSA-N 18:3n-3 Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OC DVWSXZIHSUZZKJ-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000131066 Coccinella Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- DVWSXZIHSUZZKJ-YSTUJMKBSA-N methyl linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OC DVWSXZIHSUZZKJ-YSTUJMKBSA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
【課題】メラニンの生成を抑制し、日焼け後の色素沈着・しみ・そばかす・肝班等の予防および改善に有効なチロシナーゼ活性阻害作用を有し、皮膚の美白に優れた効果を有する美白剤および美白効果に優れた美白化粧料と共に、優れた抗酸化効果を有することにより皮膚老化を防止し、にきび、アトピー性皮膚炎、アレルギー性皮膚炎およびふけ防止などに有効な抗酸化剤およびこれらの効果に優れた皮膚外用剤の提供を課題とした。
【解決手段】ツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物が優れたチロシナーゼ活性阻害作用および抗酸化作用を有することを見出した。
【選択図】なしA whitening agent that suppresses the production of melanin, has a tyrosinase activity inhibitory effect effective in preventing and improving pigmentation, stains, freckles, liver spots, etc. after sunburn, and has an excellent effect on skin whitening, and Anti-oxidant effective in preventing skin aging and preventing acne, atopic dermatitis, allergic dermatitis and dandruff etc It was an issue to provide a skin external preparation excellent in skin resistance.
The present invention has found that an extract of the genus Coccinaceae (scientific name: Vaccinium dunalianum var. Urophyllum) has excellent tyrosinase activity inhibitory activity and antioxidant activity.
[Selection figure] None
Description
本発明は、特定の植物の抽出物を配合することにより、メラニンの生成を抑制し、日焼け後の色素沈着・しみ・そばかす・肝班等の予防および改善に有効なチロシナーゼ活性阻害作用を有する美白剤および皮膚の美白に優れた効果を有する美白化粧料に関すると共に、優れた抗酸化効果を有することにより皮膚老化を防止し、にきび、アトピー性皮膚炎、アレルギー性皮膚炎およびふけ防止などに有効な抗酸化剤およびこれらの効果に優れた皮膚外用剤に関する。 The present invention contains a specific plant extract to suppress the production of melanin, and has a tyrosinase activity inhibitory effect effective in preventing and improving pigmentation, stains, freckles, liver spots, etc. after sunburn. In addition to the agent and whitening cosmetics that have an excellent effect on skin whitening, it has an excellent antioxidant effect to prevent skin aging and is effective in preventing acne, atopic dermatitis, allergic dermatitis and dandruff The present invention relates to an antioxidant and an external preparation for skin excellent in these effects.
皮膚のしみやそばかす等の色素沈着は、紫外線やその他の刺激により引き起こされるメラニン色素の過剰な合成の亢進の結果とされており、美容上大きな問題となる。 Pigmentation such as skin spots and freckles is a result of excessive synthesis of melanin pigments caused by ultraviolet rays and other stimuli, and is a major cosmetic problem.
このメラニン色素は、表皮の一番下の基底層に存在するメラニン細胞(メラノサイト)内のメラニン生成顆粒(メラノソーム)において産生され、生成したメラニンは浸透作用により隣接細胞へ拡散する。このメラノサイト内における生化学反応は、次の様に考えられている。 This melanin pigment is produced in melanin-producing granules (melanosomes) in melanocytes (melanocytes) existing in the basal layer at the bottom of the epidermis, and the produced melanin diffuses to adjacent cells by osmotic action. The biochemical reaction in this melanocyte is considered as follows.
すなわち、必須アミノ酸であるチロシンが酵素チロシナーゼの作用によりドーパキノンになり、これが酵素的又は非酵素的酸化作用により、赤色色素及び無色色素を経て黒色のメラニン色素へ変化する過程がメラニン色素の生成過程である。従って、反応の第1段階であるチロシナーゼの作用を抑制することが、メラニン生成の抑制に重要である。(特許文献1,2参照)
従来は、しみ、そばかすを防ぐためにメラニンの生成を抑制する物質が用いられており、例えばL−アスコルビン酸、L−アスコルビン酸−2−リン酸マグネシウム、L−アスコルビン酸グルコシド、システイン、アルブチン、グルタチオン等の美白薬剤を軟膏、クリーム、ローションなどの剤型にして、局所に塗布する方法が一般的である。また、グルタチオン等の還元性アミノ酸を局所に注射する方法も行われている。しかしながらこれら美白化粧料等は、必ずしも有効性が十分であるとはいえず、美白効果、更には美肌効果を高めることが求められていた。また、これら物質は皮膚に対する作用が強いため安全性の点で問題が見られるものがあり、皮膚に対しマイルドな美白剤が求められてきた。
That is, tyrosine, an essential amino acid, is converted to dopaquinone by the action of the enzyme tyrosinase, and this process changes from red and colorless pigments to black melanin pigments by enzymatic or non-enzymatic oxidation. is there. Therefore, suppressing the action of tyrosinase, which is the first stage of the reaction, is important for suppressing melanin production. (See Patent Documents 1 and 2)
Conventionally, substances that suppress the production of melanin have been used to prevent stains and freckles. For example, L-ascorbic acid, L-ascorbic acid-2-magnesium phosphate, L-ascorbic acid glucoside, cysteine, arbutin, glutathione A method of applying a whitening agent such as ointment, cream, lotion and the like to a topical application is common. In addition, a method of locally injecting a reducing amino acid such as glutathione is also performed. However, these whitening cosmetics and the like cannot always be said to be sufficiently effective, and there has been a demand for enhancing the whitening effect and further the skin beautifying effect. In addition, since these substances have a strong action on the skin, there are some problems in terms of safety, and mild whitening agents for the skin have been demanded.
また、近年、生体内における活性酸素の生成とそれによって起こる様々な影響が報告されており、皮膚は直接的に外界と接する器官であるために環境因子の影響を受けやすく、紫外線や放射線などによって活性酸素が皮膚に過剰状態になると、生体膜リン脂質の不飽和脂肪酸などと反応し過酸化脂質が生成する。この過酸化脂質によってタンパク変性、膜の破壊、老化、発ガンなどを引き起こすおそれがあり、肌荒れや皮膚老化の原因となる。このような背景から、抗酸化剤としてビタミンE、ビタミンCやオリザノール、種々の植物エキス(ハマメリス、チョウジ、ローズマリー、エイジツ、ケイヒ、甘草)などが過剰な活性酸素を消去するために用いられてきたが、その酸化防止作用は弱いものであり効果が不十分であった。化粧料に配合することにより皮膚の脂質成分の酸化防止や皮膚の酸化障害、皮膚老化に有効性を発揮する新しい抗酸化剤の開発が強く要求されているのが現状である。(特許文献3,4、5参照)
本発明は上記事情に鑑みてなされたもので、その目的は、優れたチロシナーゼ活性阻害作用を有し美白効果に優れた美白剤および美白化粧料、さらに優れた抗酸化効果を有することにより皮膚老化を防止し、にきび、アトピー性皮膚炎、アレルギー性皮膚炎およびふけ防止などに有効な抗酸化剤およびこれらの効果に優れた皮膚外用剤を提供することにある。 The present invention has been made in view of the above circumstances, and the purpose thereof is skin aging by having an excellent tyrosinase activity inhibitory action and a whitening effect excellent in a whitening effect, and further having an excellent antioxidant effect. It is to provide an antioxidant effective for preventing acne, preventing acne, atopic dermatitis, allergic dermatitis and dandruff, and a skin external preparation excellent in these effects.
本発明者は、広く種々の物質についてチロシナーゼ活性阻害作用および抗酸化作用を調べた結果、ツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物が優れたチロシナーゼ活性阻害作用および抗酸化作用を有することを見出し、本発明を完成するに至った。ツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物のチロシナーゼ活性阻害作用に関する報告はこれまでになく、美白剤、抗酸化剤としての応用はおろか、皮膚外用剤への応用も知られていない。 As a result of investigating the tyrosinase activity inhibitory action and antioxidant action of a wide variety of substances, the present inventor has found that an extract of the genus Ezoaceae genus Echinacea (scientific name Vaccinium dunalianum var. Urophyllum) has an excellent tyrosinase activity inhibitory action and It has been found that it has an antioxidant action, and has led to the completion of the present invention. There has been no report on the tyrosinase activity inhibitory action of an extract of the genus Azalea, Vaccinium dunalianum var. Urophyllum, and it has not been used as a whitening agent, an antioxidant, or an application to an external skin preparation. Is also not known.
すなわち、本発明はツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物を配合することを特徴とする皮膚外用剤に関する。また、ツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物を有効成分とする美白剤および抗酸化剤である。 That is, this invention relates to the skin external preparation characterized by mix | blending the extract of the genus Coccinaceae genus Cusnohaco biloba (scientific name Vaccinium dunalianum var. Urophyllum). In addition, it is a whitening agent and an antioxidant containing as an active ingredient an extract of the genus Ezocephalum genus Cusnohaco biloba (scientific name: Vaccinium dunalianum var. Urophyllum).
本発明によれば、チロシナーゼ活性阻害作用を有し、美白効果に優れた美白剤が得られ、日焼け後の色素沈着、しみ、そばかす、肝班等の予防および改善に優れた美白化粧料を得ることができ、さらに優れた抗酸化効果を有することにより皮膚老化を防止し、にきび、アトピー性皮膚炎、アレルギー性皮膚炎およびふけ防止などに有効であり、さらに抗菌や消臭効果を有する抗酸化剤およびこれらの効果に優れた皮膚外用剤を得ることが出来る。 According to the present invention, a whitening agent having an inhibitory effect on tyrosinase activity and having an excellent whitening effect can be obtained, and a whitening cosmetic preparation having excellent prevention and improvement of pigmentation, sunburn, freckles, liver spots and the like after sunburn can be obtained. Antioxidant with antibacterial and deodorizing effects, which is effective in preventing skin aging by having an excellent antioxidative effect, and is effective in preventing acne, atopic dermatitis, allergic dermatitis and dandruff And a skin external preparation excellent in these effects can be obtained.
以下、本発明の構成を更に詳細に説明する。 Hereinafter, the configuration of the present invention will be described in more detail.
本発明に用いられるツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)は、中国雲南省、広西省、モンゴル南部の海抜2000〜2700mの森あるいは広葉樹林で成育するものであり、中国名では樟葉越橘と言う。本発明に用いられるツツジ科コケモモ属のクスノハコケモモの抽出物はクスノハコケモモの葉、茎、芽、花、種子または植物全草等を抽出溶媒と共に浸漬または加熱還流した後、ろ過し濃縮して得られる。 The azalea family genus Coccinella genus used in the present invention (scientific name: Vaccinium dunalianum var. Urophyllum) grows in forests or broad-leaved forests of 2000-2700 m above sea level in Yunnan, Guangxi, southern Mongolia, China. In its name, it is Tsubaki Koshiba Tachibana. The extract of the genus Coxnochacoceae used in the present invention is the leaves, stems, buds, flowers, seeds, or whole plant plants of the genus Coxnocochidae soaked or heated under reflux together with the extraction solvent, filtered and concentrated. Obtained.
さらに詳しくは、クスノハコケモモを溶媒、たとえば水、低級アルコール、含水低級アルコール、プロピレングリコール、1,3−ブチレングリコール、ブタノール等の極性溶媒またはクロロホルム、酢酸エチル、エーテル等あるいはこれらの混合物の有機溶媒で抽出して得た抽出物をそのまま、あるいは濃縮したエキスを用いるか、エキスを吸着法、たとえばイオン交換樹脂を用いて不純物を除去したものや、ポーラスポリマーのカラムに吸着させた後、メタノールまたはエタノールで溶出し濃縮したエキスも使用できる。また、分配法、たとえばブタノールで抽出した抽出物等も使用できる。 In more detail, kusunochakebomo is a solvent, for example, a polar solvent such as water, lower alcohol, hydrous lower alcohol, propylene glycol, 1,3-butylene glycol, butanol, or an organic solvent such as chloroform, ethyl acetate, ether, or a mixture thereof. The extract obtained by extraction in (1) is used as it is or a concentrated extract, or the extract is adsorbed, for example, after removing impurities using an ion exchange resin, or after being adsorbed on a porous polymer column, methanol or Extracts eluted and concentrated with ethanol can also be used. Also, a partitioning method, for example, an extract extracted with butanol can be used.
製法の具定的な一例をあげると、クスノハコケモモの葉を50〜100%エタノール水溶液で熱時抽出し、冷却後、不溶物をろ過し、ろ液を減圧下で濃縮し析出する沈殿物をろ過して除く、ろ液はさらに濃縮後放置し析出する結晶を集め、水で再結晶を繰り返すことによってクスノハコケモモの濃縮抽出物を得ることができる。 To give a specific example of the production method, the leaves of Cusnus palmatum are extracted with 50-100% ethanol aqueous solution when heated, the insoluble matter is filtered after cooling, and the filtrate is concentrated under reduced pressure to precipitate. The filtrate is further concentrated and allowed to stand after concentration, and the precipitated crystals are collected and recrystallized repeatedly with water to obtain a concentrated extract of Cinnospider.
本発明におけるツツジ科コケモモ属のクスノハコケモモ(学名Vaccinium dunalianum var. urophyllum)の抽出物の配合量は美白化粧品または皮膚外用剤の全量中、固形分濃度で0.005〜20.0%、好ましくは0.01〜10.0%である。 In the present invention, the amount of the extract of the genus Coccinaceae (Vaccinium dunalianum var. Urophyllum) in the azalea family is 0.005 to 20.0%, preferably in a solid content concentration in the total amount of the whitening cosmetic or skin external preparation. Is 0.01 to 10.0%.
本発明の美白化粧料または皮膚外用剤にはクスノハコケモモ抽出物とともに、既存の美白薬剤であるL−アスコルビン酸、L−アスコルビン酸−2−リン酸ナトリウム、L−アスコルビン酸−2−リン酸マグネシウム、L−アスコルビン酸グルコシド、テトラヘキシルデカン酸アスコルビル、システイン、アルブチン、トラネキサム酸、グルタチオン等を配合してもよい。 The whitening cosmetic or skin external preparation of the present invention includes L-ascorbic acid, L-ascorbic acid-2-sodium phosphate, L-ascorbic acid-2-phosphoric acid, which are existing whitening agents, together with an extract of Kusunochakebomo. Magnesium, L-ascorbic acid glucoside, ascorbyl tetrahexyldecanoate, cysteine, arbutin, tranexamic acid, glutathione and the like may be blended.
また、本発明の皮膚外用剤には、ビタミンE、ビタミンC、ビタミンB2、カロチノイド、フラボノイド、サポニン、タンニン、コエンザイムQ10やオリザノール等の抗酸化剤とそれらの誘導体、種々の植物エキス(ハマメリス、チョウジ、ローズマリー、エイジツ、ケイヒ、甘草)等を配合してもよい。 The skin external preparation of the present invention includes antioxidants such as vitamin E, vitamin C, vitamin B2, carotenoid, flavonoid, saponin, tannin, coenzyme Q10 and oryzanol and their derivatives, various plant extracts (hamamelis, clove) , Rosemary, age, keihi, licorice) and the like.
本発明の美白化粧料または皮膚外用剤には、本発明の効果を損なわない範囲で化粧品、医薬部外品等で通常用いられているものを配合することが出来るが、その例として、流動パラフィンなどの炭化水素、植物油脂、ロウ類、合成エステル油、シリコーン系の油相成分、フッ素系の油相成分、高級アルコール類、脂肪酸類、増粘剤、紫外線吸収剤、粉体、顔料、色材、陰イオン性界面活性剤、陽イオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤、多価アルコール、糖、高分子化合物、生理活性成分、経皮吸収促進剤、溶媒、酸化防止剤、香料、防腐剤等を配合することができる。 The whitening cosmetic or skin external preparation of the present invention can be blended with what is usually used in cosmetics, quasi-drugs and the like as long as the effects of the present invention are not impaired. Hydrocarbons, vegetable oils and fats, waxes, synthetic ester oils, silicone oil phase components, fluorine oil phase components, higher alcohols, fatty acids, thickeners, UV absorbers, powders, pigments, colors Material, anionic surfactant, cationic surfactant, nonionic surfactant, amphoteric surfactant, polyhydric alcohol, sugar, polymer compound, physiologically active ingredient, transdermal absorption enhancer, solvent, Antioxidants, fragrances, preservatives and the like can be blended.
その他、エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸などの金属封鎖剤を配合することが出来る。 In addition, metal sequestering agents such as edetate disodium, edetate trisodium, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid can be blended.
本発明に係る美白化粧料および皮膚外用剤はスキンケア化粧品だけでなく、ファンデーションや口紅などのメーキャップ化粧品やヘアクリームおよびヘアトニックなどの毛髪化粧品にも応用することができ、その剤型は任意であり、化粧水、ローション、乳液、クリーム、パック、軟膏、分散液、固形物、ムース、等の任意の剤型をとることができる。 The whitening cosmetic and skin external preparation according to the present invention can be applied not only to skin care cosmetics, but also to makeup cosmetics such as foundations and lipsticks, and hair cosmetics such as hair creams and hair tonics. , Lotions, lotions, emulsions, creams, packs, ointments, dispersions, solids, mousses, and the like.
以下に実施例を挙げて本発明を具体的に説明するが、本発明の技術的範囲がこれらに限定されるものではない。
(1)チロシナーゼ活性阻害効果
本発明に係る化合物のチロシナーゼ活性阻害効果及び美白効果について、以下の試験を行った。
<試料の調製>
(1) クスノハコケモモ抽出物1
クスノハコケモモの葉100gを50%エタノール水溶液に1日間浸漬した後、抽出液を濃縮し5.3gの固形分を得た。
(2) クスノハコケモモ抽出物2
クスノハコケモモの葉100gを60%エタノール水溶液で熱時抽出し、冷却後不溶物をろ過し、ろ液を減圧下で濃縮し最初に析出する沈殿物をろ過して除く。ろ液はさらに濃縮後放置し、析出する沈殿を集め、水で再結晶を3回行い2.3gの固形分を得た。
<実験方法>
正常メラノサイトを0.1%Toriton X−100含有リン酸緩衝液(100mM,pH6.8)で、3.0×105cell/mLの濃度になるよう溶解し、これをチロシナーゼ粗酵素溶液とした。粗酵素溶液のドーパオキシダーゼ活性を測定することにより試料のチロシナーゼ活性に与える作用を評価した。ドーパオキシダーゼ活性は96穴マイクロプレートに粗酵素溶液を50μLずつ分注し、L−DOPA(0.25mg/mLリン酸緩衝液(50mM、pH6.8))および所定濃度の試料を添加して反応を開始した。開始直後および37℃、2時間インキュベート後の405nmにおける吸光度をマイクロプレートリーダーにて測定した。市販の合成メラニンで作成した検量線を用いて生成したメラニン量を算出した。チロシナーゼ活性は、単位時間および酵素液の単位タンパク質量あたりのメラニン生成量として算出した。
EXAMPLES The present invention will be specifically described below with reference to examples, but the technical scope of the present invention is not limited to these examples.
(1) Tyrosinase activity inhibitory effect The following test was done about the tyrosinase activity inhibitory effect and the whitening effect of the compound which concerns on this invention.
<Preparation of sample>
(1) Kusunohokoberry extract 1
After immersing 100 g of camphor leaf leaves in 50% ethanol aqueous solution for 1 day, the extract was concentrated to obtain 5.3 g of solid content.
(2) Kusunohokoberry extract 2
100 g of blackberry leaves are extracted with a 60% aqueous ethanol solution when heated, the insoluble matter is filtered after cooling, the filtrate is concentrated under reduced pressure, and the first deposited precipitate is removed by filtration. The filtrate was further concentrated and allowed to stand, and the deposited precipitate was collected and recrystallized three times with water to obtain 2.3 g of a solid content.
<Experiment method>
Normal melanocytes were dissolved in a phosphate buffer solution (100 mM, pH 6.8) containing 0.1% Torton X-100 to a concentration of 3.0 × 10 5 cells / mL, and this was used as a tyrosinase crude enzyme solution. . The effect of the crude enzyme solution on the tyrosinase activity of the sample was evaluated by measuring the dopa oxidase activity of the crude enzyme solution. The dopa oxidase activity was obtained by dispensing 50 μL of the crude enzyme solution into a 96-well microplate and adding L-DOPA (0.25 mg / mL phosphate buffer (50 mM, pH 6.8)) and a sample with a predetermined concentration. Started. The absorbance at 405 nm was measured with a microplate reader immediately after the start and after incubation at 37 ° C. for 2 hours. The amount of melanin produced was calculated using a calibration curve created with commercially available synthetic melanin. Tyrosinase activity was calculated as the amount of melanin produced per unit time and the amount of protein in the enzyme solution.
また、参考例として、すでにチロシナーゼ活性阻害作用があることが知られているアルブチンについても上記と同様の試験を行った。
<結果>
結果を表1に示す。
As a reference example, arbutin, which is already known to have a tyrosinase activity inhibitory effect, was also tested in the same manner as described above.
<Result>
The results are shown in Table 1.
表1の結果より本発明のクスノハコケモモ抽出物は、優れたチロシナーゼ活性阻害作用を示し、アルブチンより優れたチロシナーゼ活性阻害作用を持つことがわかる。
(2)美白効果試験
<試験方法>
1.紫外線照射による色素沈着の作成
被験部位は日常生活で日光暴露されにくい左上腕内側部とし、各被験者の最小紅班量(MED)を右上腕内側部であらかじめ測定後、左上腕内側部に1.5MEDに相当する紫外線を照射し、直径1cmの色素沈着を作成した。光源としてMultiport Solar UV Simulator Model 601(Solar Light Co.Inc.)で波長範囲300〜400nm、ピーク波長356nmを用い、その照射強度は多機能計測システム モデルPMA2100(Solar Light Co.Inc.)を用いて測定した。
2.被験製剤
以下に示す処方の被験製剤を用いる。水中油型乳化組成物の調製方法の常法に従い被験製剤を得た。
From the results shown in Table 1, it can be seen that the cinnamon bilberry extract of the present invention exhibits an excellent tyrosinase activity inhibitory action and has a tyrosinase activity inhibitory action superior to arbutin.
(2) Whitening effect test <Test method>
1. Preparation of pigmentation by ultraviolet irradiation The test site is the inner left upper arm that is not easily exposed to sunlight in daily life. Irradiation with ultraviolet rays corresponding to 5 MED was performed to produce pigmentation with a diameter of 1 cm. As a light source, a multiport solar UV simulator model 601 (Solar Light Co. Inc.) is used with a wavelength range of 300 to 400 nm and a peak wavelength of 356 nm, and the irradiation intensity is measured using a multi-function measurement system model PMA2100 (Solar Light Co. Inc.). It was measured.
2. Test preparation A test preparation having the following formulation is used. A test preparation was obtained according to a conventional method for preparing an oil-in-water emulsion composition.
1.塗布方法および塗布期間
被験製剤はそれぞれの紫外線照射部位を含む2×2cm2に約20mgを朝夕1日2回紫外線照射直後から3週間塗布した。
2.皮膚色測定および評価
観察日に、被験部位を分光測色計CR−13(ミノルタ)を用いて測色した。測色パラメーターとしてはL*を用い、色素沈着はΔL*値(=紫外線照射前のL*値−紫外線照射後のL*値)を用いて評価した。
1. Application Method and Application Period About 20 mg of the test preparation was applied twice a day in the morning and evening for 3 weeks to 2 × 2 cm 2 including each ultraviolet irradiation site.
2. Skin color measurement and evaluation On the day of observation, the test site was measured using a spectrocolorimeter CR-13 (Minolta). L * was used as a colorimetric parameter, and pigmentation was evaluated using a ΔL * value (= L * value before ultraviolet irradiation−L * value after ultraviolet irradiation).
美白効果の評価は以下の基準で行った
×:ΔL*値がコントロールの値と同じ
△:ΔL*値が(コントロールの値−1.0)以上
○:ΔL*値が(コントロールの値−1.0)未満
<結果>
The whitening effect was evaluated according to the following criteria. X: ΔL * value is the same as control value Δ: ΔL * value is (control value −1.0) or more ○: ΔL * value is (control value−1) .0) <Result>
表3の結果より本発明のクスノハコケモモ抽出物はアルブチンより優れた美白効果を有することがわかる。
(3)抗酸化効果試験
<試験方法>
1.0mgリノレン酸メチルをアセトン1.0mLに溶解し、クスノハコケモモ抽出物1およびクスノハコケモモ抽出物2を固形分濃度で0.001mgあるいは0.01mgを添加し、ネジ付き試験管に分注・乾固後、酸化群を50℃で4時間処理し、非酸化群は4℃で保存した。処理後、非水系TBA試薬(0.12%2−チオバルビツール酸・0.50%トリエチルアミン/酢酸)3.0mLを添加し、95%で1時間反応させた。反応後直ちに水冷し、532nmの吸光度を測定し、酸化抑制率を算出した。
From the results shown in Table 3, it can be seen that the cinnamon leaf extract of the present invention has a whitening effect superior to that of arbutin.
(3) Antioxidant effect test <Test method>
Dissolve 1.0 mg methyl linolenate in 1.0 mL of acetone, add 0.001 mg or 0.01 mg solid extract of Cunnochakeboko extract 1 and Cunnochakeboko extract 2 to a threaded test tube. After pouring and drying, the oxidized group was treated at 50 ° C. for 4 hours, and the non-oxidized group was stored at 4 ° C. After the treatment, 3.0 mL of a non-aqueous TBA reagent (0.12% 2-thiobarbituric acid / 0.50% triethylamine / acetic acid) was added and reacted at 95% for 1 hour. Immediately after the reaction, the mixture was cooled with water, the absorbance at 532 nm was measured, and the oxidation inhibition rate was calculated.
酸化抑制率(%)=[1−(As50−As4)/(Ac50−Ac4)]×100
Ac50 :control 50℃加熱の吸光度
Ac4 :control 4℃保存の吸光度
As50 :試料 50℃加熱の吸光度
As4 :試料 4℃保存の吸光度
なお、対象としてはクスノハコケモモ50%エタノール水溶液抽出物に変えてビタミンE(DL−α―トコフェロール、東京化成工業(株)製)、BHT(和光純薬工業(株)製)を添加したものについても同様に操作した、その結果を表4に示す。
Oxidation inhibition rate (%) = [1- (As50−As4) / (Ac50−Ac4)] × 100
Ac50: control Absorbance at 50 ° C heating Ac4: control Absorbance at 4 ° C storage As50: Sample Absorbance at 50 ° C heating As4: Absorbance at 4 ° C storage Note that the target is vitamin C instead of 50% ethanol aqueous extract Table 4 shows the results of the same operation with E (DL-α-tocopherol, manufactured by Tokyo Chemical Industry Co., Ltd.) and BHT (manufactured by Wako Pure Chemical Industries, Ltd.).
表4に示すようにクスノハコケモモ抽出物はビタミンEより優れた抗酸化作用を示し、濃度を上げるとBHTと同等の抗酸化効果を示す。 As shown in Table 4, the Kusonochaboko extract has an antioxidant effect superior to that of Vitamin E, and exhibits an antioxidant effect equivalent to that of BHT when the concentration is increased.
以下に、本発明に係る化合物を配合した美白化粧料および皮膚外用剤の実施例を挙げる。配合量は質量%を表す。 Examples of whitening cosmetics and external preparations for skin containing the compounds according to the present invention will be given below. A compounding quantity represents the mass%.
実施例1
クリーム1
(処方) 質量%
油相
セチルアルコール 7.0
ステアリルアルコール 3.0
スクワラン 4.0
ワセリン 3.0
流動パラフィン 15.0
水相
モノステアリン酸POE(20)ソルビタン
3.0
1,3−ブチレングリコール 3.0
クスノハコケモモ抽出物1 0.5
防腐剤 適量
香料 0.2
精製水 残部
(調製方法)
水中油型乳化組成物の製法の常法に従い調製した。
Example 1
Cream 1
(Prescription) Mass%
Oil phase Cetyl alcohol 7.0
Stearyl alcohol 3.0
Squalane 4.0
Vaseline 3.0
Liquid paraffin 15.0
Aqueous phase POE (20) sorbitan monostearate
3.0
1,3-butylene glycol 3.0
Kusunohokoberry extract 1 0.5
Preservative appropriate amount Fragrance 0.2
Purified water balance (preparation method)
The oil-in-water emulsion composition was prepared according to a conventional method.
実施例2
美容液
(処方) 質量%
ステアリン酸 2.5
セチルアルコール 1.5
ワセリン 3.0
流動パラフィン 15.0
モノラウリン酸デカグリセリル 1.0
モノステアリン酸POE(20)ソルビタン
3.0
キサンタンガム 0.5
1,3−ブチレングリコール 10.0
トリエタノールアミン 1.0
クスノハコケモモ抽出物2 0.3
防腐剤 適量
香料 0.2
精製水 残部
(調製方法)
水中油型乳化組成物の製法の常法に従い調製した。
Example 2
Essence (Prescription) Mass%
Stearic acid 2.5
Cetyl alcohol 1.5
Vaseline 3.0
Liquid paraffin 15.0
Decaglyceryl monolaurate 1.0
Monostearic acid POE (20) sorbitan
3.0
Xanthan gum 0.5
1,3-butylene glycol 10.0
Triethanolamine 1.0
Kusunohokoberry extract 2 0.3
Preservative appropriate amount Fragrance 0.2
Purified water balance (preparation method)
The oil-in-water emulsion composition was prepared according to a conventional method.
実施例3
化粧水
(処方) 質量%
オレイルアルコール 0.1
POE(20)ソルビタンモノラウリン酸エステル
0.5
POE(15)ラウリルエーテル 0.5
グリセリン 4.0
1,3−ブチレングリコール 6.0
エチルアルコール 10.0
クスノハコケモモ酢酸エチル抽出物 0.01
防腐剤 適量
香料 0.2
精製水 残部
(調製方法)
全ての成分を50℃で均一になるまで混合し、調製した。
Example 3
Lotion (Prescription) Mass%
Oleyl alcohol 0.1
POE (20) sorbitan monolaurate
0.5
POE (15) lauryl ether 0.5
Glycerin 4.0
1,3-butylene glycol 6.0
Ethyl alcohol 10.0
Kusunoha peach ethyl acetate extract 0.01
Preservative appropriate amount Fragrance 0.2
Purified water balance (preparation method)
All ingredients were mixed and prepared at 50 ° C. until uniform.
実施例4
クリーム2(エモリエントタイプ)
(処方) 質量%
油相
ステアリルアルコール 6.0
ステアリン酸 2.0
ミリスチン酸イソセチル 6.0
トリ2−エチルヘキサン酸グリセリル 3.0
マカデミアナッツ油 1.0
ジメチルポリシロキサン(6cs) 0.2
POE(20)セチルエーテル 3.0
モノステアリン酸グリセリル 2.0
水相
水素添加大豆レシチン 0.2
1,3−ブチレングリコール 5.0
クスノハコケモモ抽出物1 10.0
キサンタンガム 0.1
ヒアルロン酸ナトリウム 0.01
クエン酸 0.1
クエン酸ナトリウム 0.4
防腐剤 適量
精製水 残部
(調製方法)
水中油型乳化組成物の製造方法の常法に従い調製した。
Example 4
Cream 2 (emollient type)
(Prescription) Mass%
Oil phase Stearyl alcohol 6.0
Stearic acid 2.0
Isocetyl myristate 6.0
Glyceryl tri-2-ethylhexanoate 3.0
Macadamia nut oil 1.0
Dimethylpolysiloxane (6cs) 0.2
POE (20) cetyl ether 3.0
Glyceryl monostearate 2.0
Aqueous phase Hydrogenated soybean lecithin 0.2
1,3-butylene glycol 5.0
Kusunohokoberry extract 1 10.0
Xanthan gum 0.1
Sodium hyaluronate 0.01
Citric acid 0.1
Sodium citrate 0.4
Preservative Appropriate amount Purified water The remainder (preparation method)
It was prepared according to a conventional method for producing an oil-in-water emulsion composition.
実施例5
スキンローション
(処方) 質量%
油相
ステアリルアルコール 0.3
トリ(カプリル酸・カプリン酸)グリセリル
0.1
POP(4)POE(20)セチルエーテル 0.6
水相
プロピレングリコール 10.0
ヒアルロン酸ナトリウム 0.1
クスノハコケモモアセトン抽出物 5.0
防腐剤 適量
精製水 残部
(調製方法)
水中油型乳化組成物の製造方法の常法に従い調製した。
Example 5
Skin lotion (prescription)
Oil phase Stearyl alcohol 0.3
Tri (caprylic acid / capric acid) glyceryl
0.1
POP (4) POE (20) cetyl ether 0.6
Aqueous phase Propylene glycol 10.0
Sodium hyaluronate 0.1
Kusunoha peach acetone extract 5.0
Preservative Appropriate amount Purified water The remainder (preparation method)
It was prepared according to a conventional method for producing an oil-in-water emulsion composition.
実施例6
乳液
(処方) 質量%
油相
バチルアルコール 1.0
d−δ−トコフェロール 0.1
スクワラン 5.0
2−エチルヘキサン酸セチル 5.0
ジメチルポリシロキサン 0.5
パルミチン酸セチル 0.5
ベヘニルアルコール 1.5
ステアリン酸 0.5
親油型モノステアリン酸グリセリル 1.0
モノステアリン酸POE(20)ソルビタン
1.0
テトラオレイン酸POE(40)ソルビタン
1.5
水相
プロピレングリコール 7.0
キサンタンガム 0.1
クスノハコケモモ50%1,3−ブチレングリコール水溶液抽出物
1.0
防腐剤 適量
精製水 残部
(調製方法)
水中油型乳化組成物の製造方法の常法に従い調製した。
Example 6
Emulsion (prescription) mass%
Oil phase Batyl alcohol 1.0
d-δ-tocopherol 0.1
Squalane 5.0
Cetyl 2-ethylhexanoate 5.0
Dimethylpolysiloxane 0.5
Cetyl palmitate 0.5
Behenyl alcohol 1.5
Stearic acid 0.5
Lipophilic glyceryl monostearate 1.0
Monostearic acid POE (20) sorbitan
1.0
Tetraoleic acid POE (40) sorbitan
1.5
Aqueous phase Propylene glycol 7.0
Xanthan gum 0.1
Kusunoha peach 50% 1,3-butylene glycol aqueous solution extract
1.0
Preservative Appropriate amount Purified water The remainder (preparation method)
It was prepared according to a conventional method for producing an oil-in-water emulsion composition.
実施例7
クリーム3(油中水型エモリエントタイプ)
(処方) 質量%
油相
ジメチルポリシロキサン 4.0
ジメチコンコポリオール 0.5
デカメチルシクロペンタシロキサン 5.0
トリ(カプリル・カプリン酸)グリセリル
15.0
ミツロウ 2.0
ペンタヒドロキシ酸デカグリセリル 2.0
イソステアリン酸 1.0
水相
グリセリン 4.5
ヒアルロン酸ナトリウム 0.01
クスノハコケモモ抽出物2
3.0
防腐剤 適量
精製水 残部
(調製方法)
油中水型乳化組成物の乳化法の常法に従い、乳化組成物を調製した。
Example 7
Cream 3 (water-in-oil emollient type)
(Prescription) Mass%
Oil phase Dimethylpolysiloxane 4.0
Dimethicone copolyol 0.5
Decamethylcyclopentasiloxane 5.0
Tri (Capryl / Capric Acid) Glyceryl
15.0
Beeswax 2.0
Decaglyceryl pentahydroxy acid 2.0
Isostearic acid 1.0
Aqueous phase Glycerin 4.5
Sodium hyaluronate 0.01
Kusunohabokomomo extract 2
3.0
Preservative Appropriate amount Purified water The remainder (preparation method)
An emulsified composition was prepared according to a conventional method for emulsifying water-in-oil emulsified compositions.
実施例8
サンスクリーンクリーム
(処方) 質量%
油相
ジメチルポリシロキサン 2.5
流動パラフィン 7.0
デカメチルシクロペンタシロキサン 3.0
セチルアルコール 4.0
パラメトキシ桂皮酸オクチル 7.0
縮合リシノール酸ヘキサグリセリル 0.5
POE(20)セチルエーテル 1.0
粉体相
酸化チタン 3.0
水相
セチル硫酸ナトリウム 1.0
ステアロイルメチルタウリンナトリウム 0.3
1,3−ブチレングリコール 5.0
クスノハコケモモ抽出物1 0.8
キサンタンガム 0.3
防腐剤 適量
精製水 残部
Example 8
Sunscreen cream (prescription)
Oil phase Dimethylpolysiloxane 2.5
Liquid paraffin 7.0
Decamethylcyclopentasiloxane 3.0
Cetyl alcohol 4.0
Octyl paramethoxycinnamate 7.0
Condensed ricinoleic acid hexaglyceryl 0.5
POE (20) cetyl ether 1.0
Powder phase Titanium oxide 3.0
Aqueous phase Sodium cetyl sulfate 1.0
Stearoyl methyl taurine sodium 0.3
1,3-butylene glycol 5.0
Kusunohokoberry extract 1 0.8
Xanthan gum 0.3
Preservative appropriate amount Purified water balance
(調製方法)
粉体相を油相中に添加した後、油中水型乳化組成物の乳化法の常法に従い、乳化組成物を調製した。
(Preparation method)
After the powder phase was added to the oil phase, an emulsion composition was prepared according to a conventional method for emulsifying water-in-oil emulsion compositions.
(効果の評価)
実施例1〜実施例8の化粧品の美白効果および抗酸化効果を上記に記した美白効果試験法および抗酸化効果試験法に従って評価した結果、いずれの化粧品も美白効果および抗酸化効果が認められた。
(Evaluation of effect)
As a result of evaluating the whitening effect and the antioxidant effect of the cosmetics of Examples 1 to 8 according to the whitening effect test method and the antioxidant effect test method described above, the whitening effect and the antioxidant effect were recognized in all the cosmetics. .
本発明の美白剤は、優れたチロシナーゼ活性阻害効果を有し、日焼け後の色素沈着・しみ・そばかす・肝班等の淡色化、美白作用に優れた効果を有し、美白化粧品に応用できる。さらに優れた抗酸化効果を有することにより皮膚老化を防止し、にきび、アトピー性皮膚炎、アレルギー性皮膚炎およびふけ防止などに有効な抗酸化剤およびこれらの効果に優れた皮膚外用剤を得ることが出来る。 The whitening agent of the present invention has an excellent inhibitory effect on tyrosinase activity, has an effect of fainting pigmentation, stains, freckles, liver spots and the like after sunburn, and has an excellent effect on whitening, and can be applied to whitening cosmetics. Furthermore, it has an excellent anti-oxidant effect to prevent skin aging, and to obtain an anti-oxidant effective for acne, atopic dermatitis, allergic dermatitis and dandruff, and a skin external preparation excellent in these effects. I can do it.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005367559A JP2007169203A (en) | 2005-12-21 | 2005-12-21 | Whitening cosmetics and skin external preparations containing Kusunohakebomo extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005367559A JP2007169203A (en) | 2005-12-21 | 2005-12-21 | Whitening cosmetics and skin external preparations containing Kusunohakebomo extract |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007169203A true JP2007169203A (en) | 2007-07-05 |
Family
ID=38296248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005367559A Pending JP2007169203A (en) | 2005-12-21 | 2005-12-21 | Whitening cosmetics and skin external preparations containing Kusunohakebomo extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007169203A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007169204A (en) * | 2005-12-21 | 2007-07-05 | Nikko Chemical Co Ltd | Foods and drinks containing superoxide scavenger and Kusunoha peach extract |
CN113134026A (en) * | 2021-05-21 | 2021-07-20 | 西南林业大学 | Method for preparing bilberry extract with microwave synergistic compound enzymolysis |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05105620A (en) * | 1991-10-15 | 1993-04-27 | Kao Corp | Beautifying cosmetic comprising p-hydroxycinnamic acid derivative as active ingredient |
JPH05176785A (en) * | 1992-01-08 | 1993-07-20 | Showa Denko Kk | Production of arbutin |
JPH06153976A (en) * | 1992-11-30 | 1994-06-03 | Kikkoman Corp | Production of phenol glycoside |
JP2002097147A (en) * | 2000-09-20 | 2002-04-02 | Noevir Co Ltd | Microbial lipase inhibitor, skin care preparation against pimple and skin care preparation against dandruff containing the same |
JP2002193738A (en) * | 2000-10-05 | 2002-07-10 | L'oreal Sa | Use of at least one extract of at least one rhododendron in a composition for treating the signs of skin aging |
JP2002193734A (en) * | 2000-12-27 | 2002-07-10 | Shiseido Co Ltd | Composition for external use |
JP2002363027A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Active oxygen scavenger or cosmetic composition |
JP2002363089A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Lipid peroxide formation inhibitor or cosmetic composition |
JP2002363088A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor or cosmetic composition |
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2003012531A (en) * | 2001-07-06 | 2003-01-15 | Ichimaru Pharcos Co Ltd | Collagenease activity inhibitor or cosmetic composition |
JP2003073287A (en) * | 2001-08-30 | 2003-03-12 | Ichimaru Pharcos Co Ltd | Hyaluronidase activity inhibitor or cosmetic composition |
JP2005509659A (en) * | 2001-11-23 | 2005-04-14 | コグニス・イベリア・ソシエダッド・リミターダ | Anti-aging agent |
JP2005306850A (en) * | 2004-03-24 | 2005-11-04 | Kose Corp | Antidermopathic agent and skin lotion containing the same |
-
2005
- 2005-12-21 JP JP2005367559A patent/JP2007169203A/en active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05105620A (en) * | 1991-10-15 | 1993-04-27 | Kao Corp | Beautifying cosmetic comprising p-hydroxycinnamic acid derivative as active ingredient |
JPH05176785A (en) * | 1992-01-08 | 1993-07-20 | Showa Denko Kk | Production of arbutin |
JPH06153976A (en) * | 1992-11-30 | 1994-06-03 | Kikkoman Corp | Production of phenol glycoside |
JP2002097147A (en) * | 2000-09-20 | 2002-04-02 | Noevir Co Ltd | Microbial lipase inhibitor, skin care preparation against pimple and skin care preparation against dandruff containing the same |
JP2002193738A (en) * | 2000-10-05 | 2002-07-10 | L'oreal Sa | Use of at least one extract of at least one rhododendron in a composition for treating the signs of skin aging |
JP2002193734A (en) * | 2000-12-27 | 2002-07-10 | Shiseido Co Ltd | Composition for external use |
JP2002363027A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Active oxygen scavenger or cosmetic composition |
JP2002363089A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Lipid peroxide formation inhibitor or cosmetic composition |
JP2002363088A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor or cosmetic composition |
JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor or cosmetic composition |
JP2003012531A (en) * | 2001-07-06 | 2003-01-15 | Ichimaru Pharcos Co Ltd | Collagenease activity inhibitor or cosmetic composition |
JP2003073287A (en) * | 2001-08-30 | 2003-03-12 | Ichimaru Pharcos Co Ltd | Hyaluronidase activity inhibitor or cosmetic composition |
JP2005509659A (en) * | 2001-11-23 | 2005-04-14 | コグニス・イベリア・ソシエダッド・リミターダ | Anti-aging agent |
JP2005306850A (en) * | 2004-03-24 | 2005-11-04 | Kose Corp | Antidermopathic agent and skin lotion containing the same |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007169204A (en) * | 2005-12-21 | 2007-07-05 | Nikko Chemical Co Ltd | Foods and drinks containing superoxide scavenger and Kusunoha peach extract |
CN113134026A (en) * | 2021-05-21 | 2021-07-20 | 西南林业大学 | Method for preparing bilberry extract with microwave synergistic compound enzymolysis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8652536B2 (en) | Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof | |
JPH04342519A (en) | Skin cosmetic | |
JP4528745B2 (en) | Tyrosinase production inhibitor | |
JPH05306231A (en) | Skin external preparation | |
EP3741379A1 (en) | Cosmetic composition comprising azadirachta indica leaf extract | |
WO2010090001A1 (en) | Skin-whitening agent, anti-aging agent, and anti-oxidant agent | |
JP4975069B2 (en) | Tyrosinase inhibitor | |
KR100920896B1 (en) | Cosmetic composition for skin whitening containing blue lotus and tetrahydrocurcumin as an active ingredient | |
JP2003160461A (en) | Skin care preparation | |
JP2000169329A (en) | Cosmetic composition | |
JP3849269B2 (en) | Topical skin preparation | |
JP2007169203A (en) | Whitening cosmetics and skin external preparations containing Kusunohakebomo extract | |
JP4326512B2 (en) | Whitening agent and whitening cosmetic containing the same | |
KR20030090188A (en) | Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening | |
JPH01149706A (en) | Skin-beautifying cosmetic | |
JP4370221B2 (en) | Skin external composition | |
JPH09157151A (en) | Melanin generation inhibitor and whitening agent | |
JP3452671B2 (en) | External preparation for skin | |
JP2008247841A (en) | Skin-lightening agent and melanin generation inhibitor | |
KR100364314B1 (en) | Use of unfermented honey as a depigmenting agent | |
JP2015205833A (en) | Whitening agent containing epiphyllum oxypetalum extract | |
JPH0995436A (en) | Preparation for external use for skin | |
JP2010235483A (en) | Singlet oxygen scavenger and skin external preparation and cosmetic containing the same | |
KR100515951B1 (en) | Cosmetic Composition Comprising Sophorae Flos Extract and Arbutin for Skin Whitening | |
JP4764079B2 (en) | Whitening agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081113 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110705 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120124 |